Godlike Productions - Discussion Forum
Users Online Now: 2,165 (Who's On?)Visitors Today: 1,441,346
Pageviews Today: 2,404,693Threads Today: 967Posts Today: 17,179
10:26 PM


Back to Forum
Back to Forum
Back to Thread
Back to Thread
REPLY TO THREAD
Subject Maryland plane crash victim was a health research company CEO formerly with the CDC
User Name
 
 
Font color:  Font:








In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
Original Message Put on your tinfoil hats, ladies and gentlemen, this is about to get interesting.

-----

A pilot and CEO of a health research firm, who survived a 2010 mishap involving a plane in Gaithersburg, Maryland, was among six people killed in Gaithersburg Monday when a twin-engine plane crashed into a subdivision.

Marie Gemmell and her sons, Cole, 3, and Devon, an infant, were found in the second-floor bathroom of one of the houses struck by the plane, said Pete Piringer, the public information officer for Montgomery County Fire and Rescue.

Michael Rosenberg, CEO and founder of a North Carolina clinical development company called Health Decisions, was identified as one of the people on the airplane, according to a statement from the company. The flight originated in Chapel Hill, North Carolina, close to the company's headquarters in Durham.

[link to www.cnn.com]

-----

Although Health Decisions focuses on improving the future of clinical development, we are proud of our past. Health Decisions started with one man’s conviction that clinical development could be far more efficient. When working at the Centers for Disease Control in 1989, Dr. Michael Rosenberg realized that tedious, manual procedures were responsible not only for frequent delays in clinical trials but also for many errors requiring later correction at great expense. Government agencies and biopharma and medical device companies were spending untold billions on processes that often stretched timelines and compromised quality rather than improving it. Dr. Rosenberg recognized that improving the efficiency of clinical development would free funds to develop more life-saving products and allow those products to reach medical professionals and patients much faster.

[link to www.healthdec.com]

-----

Ebola connection? Obamacare?
Pictures (click to insert)
5ahidingiamwithranttomatowtf
bsflagIdol1hfbumpyodayeahsure
banana2burnitafros226rockonredface
pigchefabductwhateverpeacecool2tounge
 | Next Page >>





GLP